SCHEMBL1716801

SCHEMBL1716801

CC(C)=CCCC(C)=CCCC(C)CC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FNTA P49354 9/20 0.56
FNTB P49356 9/20 0.56
KMT2A Q03164 2/20 0.52
MAPT P10636 2/20 0.51
MEN1 O00255 1/20 0.51
TRPA1 O75762 1/20 0.51
KDM4E B2RXH2 1/20 0.49
ATM Q13315 1/20 0.49
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7944859 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL10405072 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL11616674 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL10405071 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL17047999 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL7942988 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL11258134 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL1716800 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL7942985 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1
SCHEMBL10749793 1.00 FNTA (0.56) FNTAFNTBKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716159-B1 BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS MOMENTIVE PERFORMANCE MAT INC (US) 2011-07-13 EP claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
US-11724838-B2 Method for producing polymer tube containing liquid and being sealed at constant intervals and apparatus for producing polymer tube SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-08-15 US disclosed
CN-108688118-B Method for producing a polymer tube filled with liquid and sealed at fixed intervals and device for producing said polymer tube 信越化学工业株式会社 2021-12-14 CN disclosed
EP-2145042-B2 TEXTILE SCENTING HENKEL AG & CO KGAA (DE) 2021-10-06 EP disclosed
US-20210161130-A1 COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOF DOMOBIOS (BE) 2021-06-03 US disclosed
US-10865002-B2 Method for producing polymer tube containing liquid and being sealed at constant intervals and apparatus for producing polymer tube SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-12-15 US disclosed
US-20200361643-A1 METHOD FOR PRODUCING POLYMER TUBE CONTAINING LIQUID AND BEING SEALED AT CONSTANT INTERVALS AND APPARATUS FOR PRODUCING POLYMER TUBE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2020-11-19 US disclosed
EP-2810558-B1 SLOW-RELEASE FORMULATION CONTAINING GEL COMPOSITION FOR USE ON PESTS SHINETSU CHEMICAL CO (JP) 2020-11-18 EP disclosed
EP-2805615-B1 SLOW-RELEASE FORMULATION CONTAINING GEL COMPOSITION FOR USE ON PESTS SHINETSU CHEMICAL CO (JP) 2020-10-14 EP disclosed
EP-2789236-B1 GEL COMPOSITION AGAINST HARMFUL INSECTS, AND SUSTAINED-RELEASE PREPARATION HAVING SAID GEL COMPOSITION INTRODUCED THEREIN SHINETSU CHEMICAL CO (JP) 2020-09-30 EP disclosed
EP-1740583-A1 OXADIAZOLONE DERIVATIVES AS PPAR DELTA AGONISTS Sanofi-Aventis Deutschland GmbH (DE) 2007-01-10 EP disclosed
WO-2005097786-A1 OXADIAZOLONE DERIVATIVES AS PPAR DELTA AGONISTS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-10-20 WO disclosed
US-4639450-A LIVER DISORDERS EISAI CO., LTD. (JP) 1987-01-27 US disclosed
US-4571408-A α,β-Dihydropolyprenyl derivatives for treating hepatitis EISAI CO., LTD. (JP) 1986-02-18 US disclosed
EP-0041235-B1 ALPHA,BETA-DIHYDROPOLYPRENYL DERIVATIVES FOR TREATING LIVER DISEASES Eisai Co., Ltd. (JP) 1985-02-13 EP disclosed
US-4481217-A TERPENE ALCOHOLS, ACIDS OR ESTERS EISAI CO., LTD. (JP) 1984-11-06 US disclosed
US-4456603-A Polyprenylcarboxylic acid amides useful for treating liver dysfunction EISAI CO., LTD. (JP) 1984-06-26 US disclosed
EP-0098620-A2 Alpha,beta-dihydropolyprenyl derivatives and a process for preparing these derivatives Eisai Co., Ltd. (JP) 1984-01-18 EP disclosed
EP-0041235-A2 Alpha,beta-dihydropolyprenyl derivatives for treating liver diseases Eisai Co., Ltd. (JP) 1981-12-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210161130-A1 COMPOSITIONS FOR ATTRACTING PESTS AND USES THEREOF ACAT1, ATL3, NISCH FNTA 128/4885FNTB 717/4885KMT2A 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.